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Abstract
Objective: To describe the level of motor performance and functional skills in young children with
JIA.
Methods: In a cross-sectional study in 56 preschool-aged (PSA) and early school- aged children
(ESA) with JIA according to ILAR classification, motor performance was measured with the Bayley
Scales of Infant Development II (BSID2) and the Movement Assessment Battery for Children (M-
ABC). Functional skills were measured with the Pediatric Evaluation of Disability Inventory (PEDI).
Disease outcome was measured with a joint count on swelling/range of joint motion, functional
ability and joint pain.
Results: Twenty two PSA children (mean age 2.1 years) with a mean Developmental Index of the
BSID2 of 77.9 indicating a delayed motor performance; 45% of PSA children showed a severe
delayed motor performance. Mean PEDI scores were normal, 38% of PSA scored below -2 SD in
one or more domains of the PEDI. Thirty four ESA children (mean age 5.2 years) with a mean M-
ABC 42.7, indicating a normal motor performance, 12% of ESA children had an abnormal score.
Mean PEDI scores showed impaired mobility skills, 70% of ESA children scored below -2 SD in one
or more domains of the PEDI. Disease outcome in both age groups demonstrated low to moderate
scores. Significant correlations were found between age at disease onset, disease duration and
BSID2 or M-ABC and between disease outcome and PEDI in both age cohorts.
Conclusion: More PSA children have more impaired motor performance than impaired functional
skills, while ESA children have more impairment in functional skills. Disease onset and disease
duration are correlated with motor performance in both groups. Impaired motor performance and
delayed functional skills is primarily found in children with a polyarticular disease course. Clinical
follow up and rehabilitation programs should also focus on motor performance and functional skills
development in young children with JIA.
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Juvenile Idiopathic Arthritis (JIA) is the most common
chronic joint disease in childhood [1]. The disease can
lead to physical disability and reduced health-related
quality of life [2]. Retrospective long-term follow-up stud-
ies have revealed significant levels of disability in adoles-
cence and adulthood JIA [3-5]. For this reason functional
status in JIA became an important outcome in clinical tri-
als and health care programs [6]. There is little knowledge
so far about the development and mastering of functional
activities in young children with JIA. Miller et al. reported
in a retrospective study of 88 school age children with
Juvenile Rheumatoid Arthritis (JRA; now referred to as
JIA) that children with JRA have significantly impaired
physical function compared to healthy children, includ-
ing those with pauci-articular JRA (now referred to as
oligo-articular JIA) [7]. This seems relevant as school-age
children are expected to have mastered a set of motor- and
functional skills that allow them to fully participate in
school activities, play and physical education. From this
perspective it is of interest whether young children with
JIA have a delayed motor performance and/or a delay in
acquiring functional skills development and whether this
is related to age at disease onset, disease course and dis-
ease severity. Only one case report by Hollister describes
the changes in motor behaviour of two children with JIA,
and concludes that the motor milestones in these children
were achieved at the same time as in their healthy peers
[8]. However, currently there are no studies that describe
the development of motor performance and functional
skills and its relationship with age at disease onset, disease
course and disease severity in young children with JIA.
Therefore the purpose of this study was to describe the
level of motor performance and the level of functional
ability in relationship to the age of disease onset, disease
course and disease outcome, in a group of preschool- and
early school- aged children with JIA.
Methods
Fifty-six consecutive children under the age of 7 years, reg-
ularly visiting the outpatient clinic of a tertiary center for
pediatric rheumatology were included in this study. All
children were classified according to the ILAR criteria [9].
All parents gave informed consent. Children with multi-
ple diagnoses were excluded from this study.
Disease history was taken retrospectively from the medi-
cal charts. Disease outcome parameters for this study were
joint swelling and joint range of motion, functional abil-
ity and reported measures of discomfort. To allow for easy
comparison all disease outcome parameters are presented
as percentage of maximal possible scores. Joint swelling
was scored for the sterno-clavicular-, glenohumoral-,
elbow-, wrist-, hand-, hip-, knee-, ankle- and foot joints
bilaterally (hand and foot joints included one or more
metacarpal or metatarsal and phalangeal joints). Classifi-
cation for joint swelling was performed on a four point
Likert scale (score range 0–3; total scale 0–54) [10]. Range
of joint motion was scored on the Pediatric Escola Pau-
lista de Medicina Range of Motion Scale (pEPM-ROM)
using a two-legged goniometer [11]. The pEPMROM
measures 10 motions (flexion/extension, abduction or
rotation) in 8 joints bilaterally (cervical spine, shoulder,
wrist, hand, hip, knee and ankle). Joint limitation for each
motion was classified on a 4-point Likert scale ranging
from no – 30% limitation in ROM (score range 0–3, total
scale 0–60). Joint status was assessed by experienced pedi-
atric physical therapists (RHHE, PvdT, JvdN) during a rou-
tine outpatient clinic visit at the department of pediatric
physical therapy. Functional ability was assessed with the
Dutch version of the Childhood Health Assessment Ques-
tionnaire parent form (CHAQ) [12,13]. The CHAQ con-
sists of eight domains with 2 or more items representing
common childhood daily activities. Each domain is repre-
sented by its worst item-score. The mean of the sum of
scores on the eight domains represents the CHAQ-disabil-
ity score (range of the scale 0–3). Perceived joint pain and
perceived disease severity are scored with a double
anchored Visual Analogue Scale and this represents the
CHAQ-discomfort score. To study the motor performance
two different, reference based, outcome measures had to
be used as there are no instruments that include an age
span from 1–7 years. We therefore stratified the patient
group in two cohorts; the preschool age children (PSA)
from 12–42 months of age and the early school age chil-
dren (ESA) from 4.0–6.9 years of age. In PSA children the
motor scale of the Dutch translation of the Bayley Scales
of Infant Development II (BSID2) was used [14,15]. This
test consists of a structured observation scale of a variable
number of motor behaviours, such as locomotor (e.g.
walking, stair climbing) and (bi) manual activities (e.g.
drawing, stacking cubes), progressive in difficulty depend-
ing on age. From the item-sumscore a Developmental
Index (DI) was calculated using original references from a
population of children of the United States of America
[14]. Normal DI's are defined as the range of +/- 2 stand-
ard deviations (score range: 70 – 130) [14]. A DI between
-1 and -2 SD is considered a delayed motor development,
a DI below -2 SD's is considered a severe delay in motor
performance.
Motor performance in ESA children was assessed using
the Dutch translation of the Movement Assessment Bat-
tery for Children (M-ABC) [16]. This test consists of 8-
items measuring manual dexterity (e.g. drawing figures,
lacing beads), ball skills (e.g. catching and bouncing) and
dynamic and static balance (e.g. 1-leg standing, jumping
a rope). In these categories, item scores can be calculated
into sum scores which can be transformed into a percen-Page 2 of 7
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tion [16]. A percentile score above the fifteenth percentile
(> P15) has been defined as 'normal motor development'.
A percentile score between the fifth (P5) and the fifteenth
percentile (P15) has been defined as 'at risk for motor
delay'. A percentile score below the fifth percentile (< P5)
has been defined as a 'severe delay in motor develop-
ment'. Functional skills was scored using the Dutch ver-
sion of the Pediatric Evaluation of Disability Inventory
(PEDI) [17]. The PEDI is a norm-referenced outcome
measure for functional ability based on a pencil and paper
questionnaire (197 items) for parents and/or caregivers.
The PEDI has shown to be a reliable and valid generic
instrument in a JIA population as well [18]. The instru-
ment consists of two major independent dimensions
(functional skills scales and caregiver assistance scales).
For this study the functional skills scales have been used
consisting of three content domains: self-care, mobility,
and social function. The mastering of functional tasks and
activities from the above mentioned domains is measured
by this scale and is expressed in standard scores. Reference
values are provided from a population from the United
States of America for children between 0.5 and 7.5 years.
Normal values are defined in the range of +/-2 standard
deviations (normal range: 30 – 70). Data for the motor
performance and functional skills are presented as mean
(SD; range). Correlations were calculated (Spearman's
Rho) between disease course, disease outcome and
motor-/functional skills. All data were entered into SPSS
data entry 3.0 and analyzed using SPSS-base 10.0 for Win-
dows (SPSS Inc, Chicago, IL, USA).
Results
A total of 56 children (36 girls and 20 boys) between 1.1
– 6.8 years of age were included in this study. At the time
of this study all children were treated in a tertiary setting
for pediatric rheumatology. In the PSA group, 22 children
(14 girls and 8 boys) were studied with a mean age of 2.1
years (SD 0.5; range 1.1 – 3.1). The mean age of onset of
disease was 1.7 years. (SD 0.5; range 1.0 – 3.0) and mean
duration was 0,9 years. (SD 0.2; range 0 – 1.0). Six chil-
dren had oligo-articular JIA, 15 had polyarticular JIA and
one child had systemic onset JIA with a polyarticular dis-
ease course. All children were on anti inflammatory or
immuno suppressive medication. Disease duration, dis-
ease outcome, motor development and development of
functional skills in the disease subtypes in PSA children
are presented in Table 1. Overall disease outcome (joint
swelling-, pEPMROM- and CHAQ-scales) in PSA children
demonstrated low to moderate scores (between 5% and
25%). The mean motor performance on the BSID2 (DI) in
PSA children was 77.9 (SD 21.2; range 55–120), on group
level indicating delayed motor development. Ten children
(45%) had a severe delayed motor development as indi-
cated by an abnormal DI on the BSID2 (< 70; i.e. < – 2
SD); all of these had a polyarticular clinical manifestation.
Five children (23%) had a delayed motor development
with a DI varying from 70 to 85, of which two had an
oligo-articular disease and three a polyarticular clinical
manifestation. One PEDI form was inadequately filled
out and therefore not included, consequently data of 21
patients were included for analysis. The mean standard
scores for the functional skills level on the PEDI domains
selfcare, mobility and social skills are 44.1 (SD 6.3),
40.6(SD 14.1) and 46.5 (SD 13.8) respectively, indicating
that the mean of functional skills in this patient group
were all within normal limits. However, five children
(23%) scored below -2 SD in one or more domains of the
PEDI functional skills scale resulting in 6 scores < -2 SD
and one child with oligo-articular JIA, four children with
polyarticular JIA. On the PEDI self- care domain all chil-
dren scored above -2 SD. On the PEDI mobility domain
four children (18%)(one oligo- and 3 polyarticular)
scored below -2 SD. On the PEDI-social skills domain two
children (both polyarticular) scored below -2 SD. In ESA
children, 34 children (22 girls and 12 boys) were studied
with a mean age of 5.2 years (SD 0.9; range 4.0–6.8), of
which 12 children had oligo-articular JIA, 14 children had
polyarticular JIA, 6 children had systemic onset JIA and 2
children with extended oligo-articular JIA. The mean age
of onset of disease was 3.0 years (SD 1.4; range 0.9–5.9)
and mean duration was 5.6 years. (SD 1.6; range 0.1 –
5.6). The clinical characteristics of ESA children are pre-
sented in Table 2, 3. One child could not be tested on the
M-ABC due to anxiety. There for 33 tests were included for
analysis. The mean motor development on the M-ABC in
ESA children was 42.7 (SD 32; range 1–96) in percentiles,
indicating a normal motor performance in this patient
cohort. However, four children (12%) had an abnormal
score, i.e. a score below the 5th percentile (one oligo-, one
extended oligo- and two polyarticular JIA). Seven children
(21%) (two oligo-, two systemic onset-, three polyarticu-
lar JIA) were considered at risk for an abnormal motor
development, i.e. a score between 5th percentile and 15th
percentile. Nine of these 11 cases had the poorest score on
the Static & Dynamic Balance subscale, i.e. the gross
motor function domain. One child scored poor on the
Ball Skills subscale (speed & dexterity), and one had a
poor score on the Fine Motor scale (i.e. eye-hand coordi-
nation & fine motor tasks). The mean functional skills
level for the whole cohort of early school age children on
the PEDI domains self-care, mobility and social skills
were 40.5 (SD 8.2), 28.7(SD 14.7) and 43.5 (SD 11.7)
respectively, indicating primarily an impairment of
mobility skills. Twenty- one children (62%) scored below
-2 SD in one or more domains of the PEDI functional
skills, ten children with oligo-articular JIA, five children
with polyarticular JIA, four children with systemic onset
JIA and two children with extended oligo-articular JIA. On
the PEDI self-care domain four children (12%) (onePage 3 of 7
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below -2 SD. On the PEDI mobility domain, 18 (55%)
children (eight oligo-, five poly-, four systemic onset and
one extended oligo-articular JIA) scored below -2 SD,
reflecting that mobility was the most impaired of all func-
tional skills. On the PEDI social skills domain, four chil-
dren (one oligo-, two poly-, and one systemic onset JIA)
scored below -2 SD.
Correlations were calculated between disease course (age
at onset, disease duration), disease outcome (joint swell-
ing, joint mobility, physical ability and joint pain), with
motor performance and skills development. In PSA chil-
dren, statistical significant correlations were found
between disease duration and pEPM-ROM (Spearman's
rho = .49; p < .05); between CHAQ, pEPM-ROM and joint
swelling (Spearman's rho = .47; p < .05 and .67; p < .001
respectively), supporting the general notion that disease
influences disease outcome. Furthermore, there was a sig-
nificant correlation between disease outcome on CHAQ
and PEDI mobility domain (Spearman's rho = -.59; p <
.01), reflecting concurrent constructs of both instruments.
The relationship between age at disease onset and BSID2
(Spearman's rho = .48; p < .5), is suggestive for the influ-
ence of disease on motor performance. In ESA children,
comparable with the PSA group, correlations were found
between disease duration and disease outcome on pEPM-
ROM, joint swelling and CHAQ (Spearman's rho = -.35; p
< .05, -.64; p < .0001 and -.45; p < .01, respectively) and
age at disease onset, joint swelling and CHAQ Spearman's
rho = .50; p < .01, .43; p < .01 respectively). The relation-
ship between disease duration and M-ABC, PEDI social
skills domain (Spearman's rho = .46; p < .01 and -.42; p <
.01, respectively), and between age at disease onset and
PEDI social skills domain (Spearman's rho = .42; p < .01)
is suggestive for a disease impact on motor performance
and skills and development. Joint swelling and joint pain
were significantly correlated with M-ABC (Spearman's rho
= -.42; p < .05 and – .37; p < .05). Joint swelling and PEDI
social skills scale were correlated (Spearman's rho = -.42;
p < .05 and .36; p < .1. These illustrate specific influence
of disease outcome parameters on motor performance
and skills development. All correlations were regarded to
be weak to modest.
Discussion
This study describes the level of motor performance and
the level of acquired functional ability in relation to clin-
ical manifestation and disease outcome in PSA children
with JIA and ESA children with JIA. More PSA children
Table 1: Disease outcome, level of motor performance and functional skills development in pre-school aged children with oligo-, 
polyarticular and systemic onset Juvenile Idiopathic Arthritis.
Preschool age
OligoJIA n = 6 Score 
n < -2sd






Min Max Mean SD Min Max Mean SD
Disease duration (yrs.) .0 1.0 .8 .4 1.0 1.0 1.0 .0 1.0
Disease Outcome (%):
Swelling index 0 55 13.3 20.9 0 40 18.5 13.4 10
ped. EPM-ROM 0 10 5.7 4.1 2 25 11.1 5.7 10
CHAQ Ds 0 35 13.3 13.3 0 75 27.3 22.3 15
VAS pain 0 45 16.7 16.9 0 75 24.6 27.6 0
VAS dis. severity 0 70 25 24.1 0 90 33.6 29.4 25
Motor skills:
BSID2 (DI) 79 120 99.8 16.7 55 108 70.33 16.9 9 60 1
Functional skills n = 14
PEDI Self-care 40.8 53.1 47.8 4.1 32.7 55.1 42.3 6.6 46.4
PEDI Mobility 20.3 68.3 47.1 16.4 1 12.8 62.9 38.6 12.9 3 30
PEDI Social skills 40.1 58.2 50 7.4 19.1 70.4 45.9 15.8 2 33.8
OligoJIA: oligo-articular Juvenile Idiopathic Arthritis, PolyJIA: polyarticular Juvenile Idiopathic Arthritis, SystJIA: Systemic onset Juvenile Idiopathic 
Arthritis, ped. EPM-ROM: pediatric Escola Paulista Medicina Range Of Motion Scale, CHAQ Ds: Childhood Health Assessment Questionnaire 
Disability Score, VAS:
Visual Analogue Scale, Dis. Severity: Disease Severity. Disease outcome is presented in % of maximum loss/impairment. BSID2 (DI): Bayley Scale of 
Infant Development II (Developmental Index; presented as index scores, +/- 2 SD's is 70–130), PEDI: Pediatric Evaluation of Disability Inventory 
(presented as standard scores, range 30–70). Abn. Score: Abnormal Score (i.e. < -2 SD). n < -2 SD: number of patients with abnormal score.Page 4 of 7
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Table 2: Disease outcome, level of motor performance and functional skills development in early school aged children with oligo-, 
polyarticular and systemic onset Juvenile Idiopathic Arthritis.
Early school age
OligoJIA n = 12 Abn. score PolyJIA n = 14 Abn. score
Min Max Mean SD Min Max Mean SD
Disease duration (yrs.) .5 5.3 2.7 1.5 .1 5.6 2.3 1.8
Disease Outcome:
% Swelling index 0 10 1.2 3.1 0 45 12.4 15.4
% ped. EPM-ROM 0 17 2.6 5 0 60 10.3 15.6
% CHAQ Ds 0 35 7.9 11.3 0 65 23.2 23.4
% VAS pain 0 70 13.7 22.8 0 70 17.8 22.1
% VAS dis. severity 0 75 17.5 23.5 0 70 16.5 23.4
Motor skills: n = 13
M-ABC (%) 5 93 49 30.8 1 1 96 38.7 33.8 2
Functional skills
PEDI Self-care 28.7 54.8 43 8.1 1 18.3 52.1 39.4 8.7 2
PEDI Mobility 10 56.8 28 15.8 8 10 65 30.2 15.8 5
PEDI Social skills 26.6 60.5 41.1 9.1 1 22.6 71.3 44.6 12.9 2
OligoJIA: oligo-articular Juvenile Idiopathic Arthritis, PolyJIA: polyarticular Juvenile Idiopathic Arthritis, ped. EPM-ROM: pediatric Escola Paulista 
Medicina Range Of Motion Scale, CHAQ Ds: Childhood Health Assessment Questionnaire Disability Score, VAS: Visual Analogue Scale, Dis. 
Severity: Disease Severity. Disease outcome is presented in % of maximum loss/impairment. M-ABC: Movement Assessment Battery for Children 
(presented as percentile scores), PEDI: Pediatric Evaluation of Disability Inventory (presented as standard scores, range 30–70). Abn. Score: 
Abnormal Score (i.e. < -2 SD).
Table 3: Disease outcome, level of motor performance and functional skills development in early school aged children with systemic 
onset- and extended oligoarticular Juvenile Idiopathic Arthritis.
Early school age
systJIA n = 6 Abn. score Ext-OligoJIA n = 2 Abn. score
Min Max Mean SD Min Max Mean SD
Disease duration (yrs.) .5 2.8 1.4 .9 .5 3.9 2.2 2.4
Disease Outcome:
% Swelling index 0 15 4.2 5.8 1 20 10.5 13.4
% ped. EPM-ROM 0 10 4.2 3.7 0 30 15 21.2
% CHAQ Ds 0 65 20 22.8 10 37 23.5 19.1
% VAS pain 0 45 13.7 20 5 87 46 57.9
% VAS dis. severity 0 50 26.5 25.4 0 85 42.5 60.1
Motor skills:
M-ABC (%) 6 93 38.8 31.6 5 79 42 52.3 1
Functional skills
PEDI Self-care 28.6 48 37 6.7 1 35.6 50.7 43.1 10.6
PEDI Mobility 12.2 48.1 29.5 12 4 10 27.1 18.5 12.1 1
PEDI Social skills 28.7 72 47.2 15.6 1 36.8 39.5 38.1 1.9
SystJIA: Systemic onset Juvenile Idiopathic Arthritis, Ext-Oligo JIA: extended oligo articular Juvenile Idiopathic Arthritis ped. EPM-ROM: pediatric 
Escola Paulista Medicina Range Of Motion Scale, CHAQ Ds: Childhood Health Assessment Questionnaire Disability Score, VAS:
Visual Analogue Scale, Dis. Severity: Disease Severity. Disease outcome is presented in % of maximum loss/impairment. M-ABC: Movement 
Assessment Battery for Children (presented as percentile scores), PEDI: Pediatric Evaluation of Disability Inventory (presented as standard scores, 
range 30–70). Abn. Score: Abnormal Score (i.e. < -2 SD).
Pediatric Rheumatology 2008, 6:2 http://www.ped-rheum.com/content/6/1/2showed impairment of motor performance on the BSID2
(± 70%) than ESA children on the M-ABC (± 35%). Our
finding is in contrast with Hollister's conclusion, thus far
the only study to specifically address the topic of motor
development in JIA. In Hollister's study no differences
were found between the moment 2 children with JIA had
reached their motor milestones compared to that of
healthy peers [8]. The low number of patients (n = 2) in
this case report has most likely biased its conclusion. Our
observation that more PSA children compared to ESA
children show impaired motor development may well be
explained by the fact that motor development at a young
age shows higher sequence of consecutive motor skills
than at older ages and therefore the impact of the disease
on motor performance is much stronger at early ages.
Other explanations for this observation could be the fact
that motor development is a process of 'jumps and
bumps' and that our one-time measurement coincided
with a 'bump' [19]. Or that young children tend to adapt
much faster to new circumstances than older children do,
by that 'self- limiting' their motor behavior, and this may
also contribute to the observation that more very young
children show impaired motor development. The results
from our study however, do stress the need for a longitu-
dinal and systematic inventory of motor development in
especially very young children with JIA for at least 5 con-
secutive years. A greater number of ESA children (55%)
compared to PSA children (± 20%) showed impaired
functional ability on the PEDI, especially in the mobility
domain. This finding is in accordance with the results
reported by Miller et al, from a retrospective study where
school age children with JIA (with and without manifest
synovitis) were compared with healthy controls. His
patient population was somewhat older, mean age ± 9.5
years and he reported loss of physical functioning
(CHAQ) between 10% and ± 65% measured [7]. In our
study the CHAQ and PEDI show sufficient correlation (-
.59) to support the conclusion that both groups show
comparable functional disability. The CHAQ however is a
non- referenced- based, disease specific, outcome measure
for childhood rheumatic conditions and in comparison
with the PEDI, a reference based generic developmental
instrument, is less specific in detecting developmental
delay. Our findings therefore allow us to be more precise
in the nature and magnitude of the developmental delay
in functional abilities. An explanation for the differences
found in mobility between PSA and ESA children might
be found in the greater demands and expectations for
independence in older children together with higher
lower extremity involvement which is more common
among JIA disease courses than upper extremity involve-
ment [1,20]. Disease course is likely to have an influence
on motor performance and functional skills. However,
the small number of each subclass of JIA in our two
cohorts makes it impossible to draw final conclusions. We
also find that duration of the disease or age at onset in
both age cohorts were correlated with the outcome on the
motor performance levels which leaves room for specula-
tion that disease exposure time may contribute to the
motor delay on the BSID2 and M-ABC. The complete lack
of correlation between motor performance and functional
skills need to be further studied. However, speculating on
this, one could hypothesize that a child with JIA uses dif-
ferent motor strategies for mastering motor and func-
tional skills. Finally, the distribution of disease subtypes
of our patient group was typical for a tertiary centre for
pediatric rheumatology, with an overrepresentation of the
more severe cases and the more severe subtypes (polyar-
ticular, systemic onset and extended oligo-articular JIA).
This could have influenced the outcome on the BSID2, M-
ABC and PEDI and may have resulted into an overrepre-
sentation of the impairment level, rather than an under-
representation in comparison with the JIA population in
general. However, the over-representation of girls in this
study population is in agreement with the literature on
gender distribution in JIA and was therefore of no concern
to the researchers [1,20].
Conclusion
In a study of 56 children with JIA, the PSA children with
JIA suffered more from impaired motor performance than
from impaired functional skills, while ESA children with
JIA showed more impairment in the performance of func-
tional skills. Disease onset and disease duration show a
correlation with motor performance in both cohorts.
Motor performance does not seem to be correlated with
performance of functional skills in both PSA- and ESA
children with JIA. The results from this study draw the
attention to an area not yet frequently studied, i.e. motor
performance and functional skills development in child-
hood chronic arthritis. Clinicians involved in the follow
up of these patients should be aware of the functional
impact joint disease has as well as the feasibility to reliable
measure this outcome. Those who are responsible for the
rehabilitation of PSA- and ESA children should be aware
of the different impact joint disease has in these age
groups and design therapeutic programs accordingly.
Future research should use longitudinal designs and focus
on predictors of motor delay and delay in development of
functional skills to further improve the efficacy of rehabil-
itation programs and follow up protocols.
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